| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Bostofte E et al. | Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation. | 1978 | Acta Endocrinol. | pmid:347855 |
| Mauvais-Jarvis P et al. | [In vivo studies on metabolism of androgens following administration of steroid inhibitors of ovulation. 1. Changes in the secretion of androgens and excretion of their metabolites in normal subjects and women with the Stein-Leventhal syndrome]. | 1965 | Acta Endocrinol. | pmid:5897059 |
| Singh H et al. | Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate. | 1982 | Acta Endocrinol. | pmid:7058686 |
| Loraine JA et al. | Hormone excretion patterns during and ater the long-term administration of oral contraceptives. | 1965 | Acta Endocrinol. | pmid:5897062 |
| Odlind V and Johansson ED | Free norethisterone as reflected by saliva concentrations of norethisterone during oral contraceptive use. | 1981 | Acta Endocrinol. | pmid:7197450 |
| Hagen C et al. | Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women. | 1982 | Acta Endocrinol. | pmid:6812338 |
| Nuttal ID and Elstein M | Steroid releasing vaginal rings. | 1980 | Acta Eur. Fertil. | pmid:6781195 |
| Beck LR and Cowsar D | Biodegradable microsphere contraceptive system. | 1980 | Acta Eur. Fertil. | pmid:7211111 |
| De Cecco L et al. | Effectiveness of norethisterone enantate in the treatment of the climacteic syndrome. | 1982 | Acta Eur. Fertil. | pmid:7186258 |
| Kesserü-Koós E et al. | Fertility control with norethindrone enanthate, a long-acting parenteral progestogen. | 1973 | Acta Eur. Fertil. | pmid:4802108 |
| Dexeus S and Fernández-Cid A | [Cytological changes produced by anovulatories and intrauterine devices]. | 1975 | Acta Ginecol (Madr) | pmid:1092123 |
| Kendall AG and Charlow GF | Red cell pyruvate kinase deficiency: adverse effect of oral contraceptives. | 1977 | Acta Haematol. | pmid:402766 |
| BRAUNSTEINER H and BRAITENBERG H | [PREVENTION OF SEVERE MENO- AND METRORRHAGIA IN HEMATOLOGICAL DISEASE BY MEANS OF AN OVULATION INHIBITOR]. | 1963 | Acta Haematol. | pmid:14073427 |
| Ask-Upmark E | Progestin, thrombophlebitis and migraine. | 1967 | Acta Med Scand | pmid:4951472 |
| Böttiger LE and Westerholm B | Oral contraceptives and thromboembolic disease. Swedish experience. | 1971 | Acta Med Scand | pmid:5149274 |
| Larsson-Cohn U and Stenram U | Liver ultrastructure and function in icteric and non-icteric women using oral contraceptive agents. | 1967 | Acta Med Scand | pmid:6066986 |
| Herbai G and Werner I | Sheehan's syndrome of hypothalamic origin in a woman with juvenile diabetes mellitus. | 1976 | Acta Med Scand | pmid:937082 |
| Christiansen C et al. | Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis. | 1984 | Acta Med Scand | pmid:6385631 |
| Brody S et al. | The effects of some ovulation inhibitors on the different plasma lipid fractions. | 1968 Jan-Feb | Acta Med Scand | pmid:5669819 |
| Dohtel Y | [Good results with Norethisterone in rheumatoid arthritis]. | 1971 | Acta Med Tenerife | pmid:12306322 |
| Poller L | Oral contraception and platelet aggregation. | 1971 | Acta Med. Scand. Suppl. | pmid:4113781 |
| Ambrus G et al. | Microbiological hydroxylation of norethisterone. | 1975 | Acta Microbiol Acad Sci Hung | pmid:1227249 |
| Savastano S et al. | The ovary and the immune function: our experience. | 1991 | Acta Neurol (Napoli) | pmid:1776532 |
| Yokoyama Y | Influences of gestagen upon carcinoma in situ of the cervix (a histologic study). | 1972 | Acta Obstet Gynaecol Jpn | pmid:4119434 |
| Sugawa T et al. | Observation on DNA synthesis of cancer cells in gestagen treatment of endometrial carcinoma. | 1970 | Acta Obstet Gynaecol Jpn | pmid:5467430 |
| Jirapinyo M et al. | Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. | 2003 | Acta Obstet Gynecol Scand | pmid:12911449 |
| Mugglestone CJ et al. | Combined estrogen and progestogen for the menopause. | 1980 | Acta Obstet Gynecol Scand | pmid:7004052 |
| Nygren KG and Johansson ED | The effect of norethindrone and some other synthetic gestagens upon the peripheral plasma levels of progesterone and estradiol during early, human pregnancy. | 1975 | Acta Obstet Gynecol Scand | pmid:46683 |
| Christiansen C et al. | Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study. | 1981 | Acta Obstet Gynecol Scand | pmid:7282308 |
| Damber MG et al. | A new and sensitive method for quantifying and comparing the biological potency of varius estrogens in man. | 1979 | Acta Obstet Gynecol Scand | pmid:550692 |
| Beckman L et al. | Induction of the "pregnancy zone" protein by oral contraceptives. | 1971 | Acta Obstet Gynecol Scand | pmid:5157502 |
| Felding C et al. | Urinary unconjugated cortisol in normally menstruating women and during estrogen-gestagen treatment. | 1986 | Acta Obstet Gynecol Scand | pmid:3799149 |
| Mousa HA and Thong J | Omental pregnancy in a woman taking the progestogen-only pill. | 2001 | Acta Obstet Gynecol Scand | pmid:11846713 |
| Serup J et al. | Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation. | 1981 | Acta Obstet Gynecol Scand | pmid:7018165 |
| Ylöstalo P and Vuopala S | Contraceptive treatment with low doses of gestagen in cases with medical history of hepatosis of pregnancy. | 1973 | Acta Obstet Gynecol Scand | pmid:4743776 |
| Starup J | Amenorrhoea following oral contraception. | 1972 | Acta Obstet Gynecol Scand | pmid:4642722 |
| Bergsjo P et al. | Tubal pregnancies in women using progestagen-only contraception. | 1974 | Acta Obstet Gynecol Scand | pmid:4440467 |
| Huovinen KJ et al. | Lynestrenol induced therapeutic amenorrhea: effects of dose reduction on serum sex-hormones and lipids. | 1992 | Acta Obstet Gynecol Scand | pmid:1317638 |
| Ylikorkala O et al. | Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate. | 2002 | Acta Obstet Gynecol Scand | pmid:12190841 |
| Wiik P et al. | Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids. | 1993 | Acta Obstet Gynecol Scand | pmid:8213103 |
| Pehrson SL | Oral contraceptives and glucose tolerance. A clinical study of three different oestrogen-progestogen combinations. | 1970 | Acta Obstet Gynecol Scand | pmid:5519500 |
| Sandström B and Löwegren L | Phlebographic studies of the leg veins in the first half of pregnancy and during oral contraception. | 1970 | Acta Obstet Gynecol Scand | pmid:5519625 |
| Dalén N et al. | Changes in bone mineral content in women with natural menopause during treatment with female sex hormones. | 1978 | Acta Obstet Gynecol Scand | pmid:726877 |
| Kullander S and Källén B | A prospective study of drugs and pregnancy. 3. Hormones. | 1976 | Acta Obstet Gynecol Scand | pmid:936986 |
| Nilsson L and Sölvell L | Clinical studies on oral contraceptives--a randomized, doubleblind, crossover study of 4 different preparations (Anovlar mite, Lyndiol mite, Ovulen, and Volidan). | 1967 | Acta Obstet Gynecol Scand | pmid:4229036 |
| Sano Y et al. | Steroid 16 alpha-hydroxylase from human fetal liver; inhibition by steroids. | 1980 | Acta Obstet Gynecol Scand | pmid:6158826 |
| Lunell NO et al. | The effects of an oral combined contraceptive on plasma levels of glucose, free fatty acids, glycerol, D- hydroxybutyrate and triglycerides. | 1973 | Acta Obstet Gynecol Scand | pmid:4688539 |
| Varma TR | Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women. | 1985 | Acta Obstet Gynecol Scand | pmid:2983513 |
| Stahlberg C et al. | Hormone replacement therapy and risk of breast cancer: the role of progestins. | 2003 | Acta Obstet Gynecol Scand | pmid:12790856 |
| Felding C | The effect of anovular treatment on the renal pelvis and ureter. | 1966 | Acta Obstet Gynecol Scand | pmid:5959367 |